Hypertrophic Cardiomyopathy (HCM)

By ACA | January 7, 2023

Joining us today to discuss septal reduction therapy in hypertrophic cardiomyopathy (HCM) is Gabor Bagameri, M.D., assistant professor of surgery in cardiovascular surgery at Mayo Clinic in Rochester, Minnesota. Tune in to learn more about septal myectomy in patients with HCM. 

Specific topics discussed:
• What are the indications for septal myectomy in patients with HCM?
• What are the surgical approaches to obstructive HCM?
• How does alcohol septal ablation compare to surgical septal myectomy in obstructive HCM?
• What is the role of arrythmia surgery during septal myectomy?
• How to manage mitral regurgitation and residual obstruction in obstructive HCM.
• When is apical myectomy indicated?

Posted in Uncategorized